Banham John Michael Middlecott - Net Worth and Insider Trading
Banham John Michael Middlecott Net Worth
The estimated net worth of Banham John Michael Middlecott is at least $330,653 dollars as of 2024-11-08. Banham John Michael Middlecott is the Director of Invesco Ltd and owns about 18,390 shares of Invesco Ltd (IVZ) stock worth over $330,652. Banham John Michael Middlecott is also the Director of Cyclacel Pharmaceuticals Inc and owns about 1 shares of Cyclacel Pharmaceuticals Inc (CYCC) stock worth over $0. Details can be seen in Banham John Michael Middlecott's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Banham John Michael Middlecott has not made any transactions after 2013-11-15 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Banham John Michael Middlecott
Banham John Michael Middlecott Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Banham John Michael Middlecott owns 2 companies in total, including Cyclacel Pharmaceuticals Inc (CYCC) , and Invesco Ltd (IVZ) .
Click here to see the complete history of Banham John Michael Middlecott’s form 4 insider trades.
Insider Ownership Summary of Banham John Michael Middlecott
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CYCC | Cyclacel Pharmaceuticals Inc | 2006-09-07 | director |
| IVZ | Invesco Ltd | 2013-11-15 | director |
Banham John Michael Middlecott Latest Holdings Summary
Banham John Michael Middlecott currently owns a total of 2 stocks. Among these stocks, Banham John Michael Middlecott owns 18,390 shares of Invesco Ltd (IVZ) as of November 15, 2013, with a value of $330,652 and a weighting of 100%. Banham John Michael Middlecott also owns 1 shares of Cyclacel Pharmaceuticals Inc (CYCC) as of September 7, 2006, with a value of $0 and a weighting of 0%.
Latest Holdings of Banham John Michael Middlecott
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| IVZ | Invesco Ltd | 2013-11-15 | 18,390 | 17.98 | 330,652 |
| CYCC | Cyclacel Pharmaceuticals Inc | 2006-09-07 | 1 | 0.47 | 0 |
Holding Weightings of Banham John Michael Middlecott
Banham John Michael Middlecott Form 4 Trading Tracker
According to the SEC Form 4 filings, Banham John Michael Middlecott has made a total of 0 transactions in Invesco Ltd (IVZ) over the past 5 years. The most-recent trade in Invesco Ltd is the sale of 3,975 shares on November 15, 2013, which brought Banham John Michael Middlecott around $134,315.
According to the SEC Form 4 filings, Banham John Michael Middlecott has made a total of 0 transactions in Cyclacel Pharmaceuticals Inc (CYCC) over the past 5 years. The most-recent trade in Cyclacel Pharmaceuticals Inc is the acquisition of 0 shares on September 7, 2006, which cost Banham John Michael Middlecott around $20,510.
Insider Trading History of Banham John Michael Middlecott
- 1
Banham John Michael Middlecott Trading Performance
GuruFocus tracks the stock performance after each of Banham John Michael Middlecott's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Banham John Michael Middlecott is 22.55%. GuruFocus also compares Banham John Michael Middlecott's trading performance to market benchmark return within the same time period. The performance of stocks bought by Banham John Michael Middlecott within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Banham John Michael Middlecott's insider trading performs compared to the benchmark.
Performance of Banham John Michael Middlecott
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -12 | | | | | |
| Relative Return to S&P 500(%) | -16.29 | | | | | |
Banham John Michael Middlecott Ownership Network
Ownership Network List of Banham John Michael Middlecott
Ownership Network Relation of Banham John Michael Middlecott
Banham John Michael Middlecott Owned Company Details
What does Cyclacel Pharmaceuticals Inc do?
Who are the key executives at Cyclacel Pharmaceuticals Inc?
Banham John Michael Middlecott is the director of Cyclacel Pharmaceuticals Inc. Other key executives at Cyclacel Pharmaceuticals Inc include director & President & C.E.O. Spiro Rombotis , director & E.V.P. & Finance & C.O.O. Paul Mcbarron , and Chief Medical Officer Mark Kirschbaum .
Cyclacel Pharmaceuticals Inc (CYCC) Insider Trades Summary
Over the past 18 months, Banham John Michael Middlecott made no insider transaction in Cyclacel Pharmaceuticals Inc (CYCC). Other recent insider transactions involving Cyclacel Pharmaceuticals Inc (CYCC) include a net purchase of 6,070 shares made by Spiro Rombotis , and a net purchase of 1,886 shares made by Paul Mcbarron .
In summary, during the past 3 months, insiders sold 0 shares of Cyclacel Pharmaceuticals Inc (CYCC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Cyclacel Pharmaceuticals Inc (CYCC) were sold and 7,956 shares were bought by its insiders, resulting in a net purchase of 7,956 shares.
Cyclacel Pharmaceuticals Inc (CYCC)'s detailed insider trading history can be found in Insider Trading Tracker table.
Cyclacel Pharmaceuticals Inc Insider Transactions
Banham John Michael Middlecott Mailing Address
Above is the net worth, insider trading, and ownership report for Banham John Michael Middlecott. You might contact Banham John Michael Middlecott via mailing address: C/o Cyclacel Pharmaceuticals, Inc., 200 Connell Drive, Suite 1500, Berkeley Heights Nj 07922.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
